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Abstract
CagA of Helicobacter pylori is a bacterium-derived oncogenic protein closely associated with the development of gastric
cancers. MicroRNAs (miRNAs) are a class of widespread non-coding RNAs, many of which are involved in cell growth, cell
differentiation and tumorigenesis. The relationship between CagA protein and miRNAs is unclear. Using mammalian miRNA
profile microarrays, we found that miRNA-584 and miRNA-1290 expression was up-regulated in CagA-transformed cells,
miRNA-1290 was up-regulated in an Erk1/2-dependent manner, and miRNA-584 was activated by NF-kB. miRNA-584
sustained Erk1/2 activities through inhibition of PPP2a activities, and miRNA-1290 activated NF-kB by knockdown of NKRF.
Foxa1 was revealed to be an important target of miRNA-584 and miRNA-1290. Knockdown of Foxa1 promoted the
epithelial-mesenchymal transition significantly. Overexpression of miRNA-584 and miRNA-1290 induced intestinal
metaplasia of gastric epithelial cells in knock-in mice. These results indicate that miRNA-584 and miRNA-1290 interfere
with cell differentiation and remodel the tissues. Thus, the miRNA pathway is a new pathogenic mechanism of CagA.
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Introduction
Helicobacter pylori (H.pylori) infection is one of the main inducers of
chronic active gastritis and peptic ulcer; it is also closely associated
with the genesis and development of gastric cancer and gastric
mucosa–associated lymphoid tissue (MALT) lymphoma. The
Union for International Cancer Control has documented H.pylori
as a type I carcinogen [1–3]. China has among the highest
incidence rates of both H.pylori infection and gastric cancer, and
the H.pylori strain positive for the virulence factor cagA (cagA+
H.pylori) is the most common type [4]. CagA plays important roles
in the genesis and development of precancerous gastric lesions,
gastric cancer, and MALT lymphoma, which indicates that CagA
is a bacterium-derived tumor-associated protein [5–7]. CagA can
destroy the apical tight junction complex of MDCK cells in a non–
phosphorylation-dependent manner to damage cell barriers,
leading to ‘‘leakage’’ between gastric mucosal epithelial cells [8].
After injection into host cells by the type IV secretion system,
CagA is phosphorylated on tyrosine residues by c-Src and Lyn
kinases. Phosphorylated CagA then associates with and activates
a bona fide oncoprotein, SHP-2, leading to Erk1/2 pathway
activation. F-actin stress fibers become highly polarized, which
leads to cytoskeleton reorganization and cell dissociation into
a ‘‘hummingbird’’-like phenotype [9–11]. In previous study, we
had found that activation of the Erk1/2 kinases by CagA directly
induces immortalized NIE epithelial cell transformation, and the
proliferation activity of transformed cells is significantly inhibited
after Erk1/2 inhibition [12]. Ohnishi et al showed that cagA-
transgenic mice develop gastric cancer and MALT lymphoma at
72 weeks [13]. Saadat et al showed that CagA causes abnormal
chromatin segregation during mitosis through SHP-2 activation of
microtubule affinity-regulating kinase [14].
MicroRNAs (miRNAs) are a class of widely distributed, non-
coding, single- stranded RNAs composed of about 19 to 22
nucleotides. In mammalian cells, miRNAs bind to 39 untranslated
regions (UTR) of mRNAs mainly through incomplete base-
pairing to inhibit gene translation at the post-transcriptional level
and thereby down-regulate the expression of target genes [15].
miRNAs regulate cell growth, differentiation, stress, and many
other biological processes [16–21]. Previous studies have found
that some miRNAs could be altered after H.pylori infection [22,23].
However, whether cagA is involved in cellular regulation of certain
miRNAs in the gastric epithelium remains elusive.
Intestinal metaplasia is a precancerous lesion of the stomach in
which there is transdifferentiation of the gastric mucosa to an
intestinal phenotype. Intestinal metaplasia of the gastric antrum is
common in adults with H.pylori–associated chronic gastritis. As we
know that intestinal meteplasia is associated with H.pylori infection,
eradication of H. pylori infection could significantly attenuate this
condition [24]. An intestine-specific transcription factor, CDX2, is
involved in the induction of intestinal metaplasia in the stomach
[25]. Whether is there is another molecular mechanism to induce
intestinal metaplasia besides CDX2 is still unknown. Therefore,
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35147we wanted to know whether the tumorigenic CagA protein also
affects the expression of miRNAs to induce intestinal metaplasia of
gastric mucosa.
Here, we found that both miRNA-584 and miRNA-1290 were
up-regulated by CagA. Overexpression of these miRNAs induced
intestinal metaplasia in knock-in mice. These results indicate that
the miRNA pathway is a new pathogenic mechanism of CagA.
Results
1. Up-regulation of miRNA-584 and miRNA-1290
Expression by CagA Protein
The pathogenesis of CagA was induced by which was injected
into epithelial cells by the type IV secretion system of H.pylori.T o
mimic injected CagA in the host cell, we first used the standard
calcium phosphate precipitation method to establish stable CagA-
expressing gastric carcinoma AGS cells to explore whether CagA
protein affects miRNA expression (Figure 1a and 1b). We then
screened for affected miRNAs in CagA-transformed gastric
carcinoma AGS cells and control empty vector–expressing cells
using mammalian miRNA expression profile microarrays. After
scanning 1024 miRNAs, we found that the expression of miRNA-
584 and miRNA-1290 was up-regulated in CagA-transformed
cells, but no down-regulated miRNA was found. These results
were further verified by TaqMan real-time PCR (Figure 1c).
Moreover, both transient transfection of cagA into gastric
carcinoma SGC7901 cells and NCTC11637 H.pylori–infected
AGS cells for 7 h yielded similar results (Figure 1d and 1e). The
above results indicate that CagA protein up-regulates miRNA-584
and miRNA-1290 expression and suggests that CagA may affect
cellular functions by altering miRNA expression.
2. miRNA-1290 was Up-regulated in an Erk1/2-dependent
Manner and miRNA-584 was Activated by NF-kB
To explore the mechanism of miRNA-584 and miRNA-1290
activation, we examined the transcript factor binding sites in the
promoter regions of miRNA-584 and miRNA-1290, and found
that there were Elk-1 binding sites in both promoter regions
(Figure S1). Elk-1 is one of the important substrates of Erk1/2
kinases. Phosphorylated Elk-1 activated by Erk1/2 kinases
potentiates ternary complex formation with serum response
element (SRE), serum response factor (SRF), and c-fos to enhance
targets’ transcription. It was confirmed that CagA could activate
Erk1/2 kinases by directly binding SHP-2 and phosphorylated
Elk-1 [26]. We also observed that transactivities of Elk-1 were up-
regulated after infection of cagA+ H.pylori (Figure 2a). To find out
whether CagA up-regulated miRNA-584 and miRNA-1290 in an
Erk1/2-dependent manner, we constructed luciferase reporters
containing the promoter regions of miRNA-584 and miRNA-1290
respectively. We found that miRNA-1290 was significantly up-
regulated by both Elk-1 and CagA in 293T cells co-transfected
with recombinant luciferase reporters and Elk-1o rcagA, whereas
miRNA-584 was not affected (Figure 2b), which implied that
there were different mechanisms for miRNA-584 and miRNA-
1290 activation. On the other hand, we examined the relationship
between miRNA-584 and miRNA-1290 in clinic tumor tissue
samples and stable miRNA-1290 –expressing cells. Interestingly,
a strong relationship was found between miRNA-584 and
miRNA-1290 in clinic tumor tissue samples (Figure S2), in
accordance with miRNA-584 being up-regulated in stable
miRNA-1290 –expressing cells (Figure 2c). This suggests that
miRNA-584 may be regulated by miRNA-1290. To analyze the
mechanism of miRNA-584 activation, we further checked the
transcript factor binding sites in the promoter regions of miRNA-
584 again besides Elk-1, and found that there were c-Rel binding
sites in the promoter regions of miRNA-584 (Figure S3).
Whether does miRNA-1290 activate the NF-kB pathway due to
the weak activation of NF-kB by CagA? To this end, we checked
the NF-kB activities by co-transfecting NF-kB reporters with
miRNA-1290 plasmids into gastric carcinoma SGC7901 cells. We
found that NF-kB activities were enhanced at 24 h after
transfection of miRNA-1290 (Figure 2d). Western blot showed
that NF-kB repressing factor (NKRF) was knockdown after
overexpression of miRNA-1290 (Figure 2e). NF-kB activities
increased after knockdown of NKRF by shRNA (Figure 2f). These
results implied that miRNA-1290 activated NF-kB by knockdown
of NKRF. Finally, we examined whether miRNA-584 was
activated by NF-kB. We found that miRNA-584 was significantly
up-regulated in SGC7901 cells co-transfected with recombinant
luciferase reporters and NKRF shRNA or c-Rel plasmids
(Figure 2g and 2h). Together, miRNA-1290 was up-regulated
in an Erk1/2-dependent manner and miRNA-584 was activated
indirectly by miRNA-1290.
3. cagA+ H.pylori Activated Erk1/2 Kinases and miRNA-
584 Sustained Erk1/2 Activities through Inhibition of
Protein Phosphatase 2a (PPP2a)
We found that Erk1/2 kinases could be activated after infection
of cagA+ H.pylori (Figure 3a). To clarify the effects of miRNA-584
and miRNA-1290 on Erk1/2 pathways, we evaluated the effects of
miRNA-584 and miRNA-1290 on Erk1/2 signaling. Recombi-
nant plasmids expressing mature miRNA-584 and miRNA-1290
were first constructed and transiently transfected into gastric
carcinoma AGS cells (Figure 3b). Kinase assays and western blot
analysis were used to detect Erk1/2 activities in transfected cells.
Expressing miRNA-584 led to higher activation of Erk1/2, but
miRNA-1290 had no significantly effect on Erk1/2 activation
(Figure 3c). A TargetScan search found two potential binding
sites for miRNA-584 in the 39-untranslational region (UTR) of
PPP2ca, one of the important phosphatases of phosphorylated
Erk1/2 (Figure S4), Further, we found that PPP2a expression
were inhibited in cells transfected with miRNA-584 (Figure 3d).
These results suggest that miRNA-584 sustained Erk1/2 activities
through inhibition of PPP2a activities.
4. Foxa1 is a Target of miRNA-584 and miRNA-1290 and
Knockdown of Foxa1 Promotes Epithelial-mesenchymal
Transition (EMT)
Besides sustaining Erk1/2 and activating NF-kB pathways,
miRNAs have hundreds of possible target genes. To identify the
key target molecules of miRNA-584 and miRNA-1290, we looked
for transcription factor targets common to both miRNA-584 and
miRNA-1290. We first used cDNA expression profile microarrays
to analyze the transcription factor profile of gastric carcinoma
AGS cells. Second, we used TargetScan to screen candidate target
transcription factors of miRNA-584 and miRNA-1290. Finally,
the target molecules of miRNA-584 and miRNA-1290 were
compared and identified (Figure 4a). Out of more than 1000
transcription factors, we obtained 15 possible miRNA-584 and 28
possible miRNA-1290 target transcription factors, of which Foxa1,
Smad2, Bach1, MITF, and HoxC13 were possibly shared in
common (Figure 4b). Among these five possible common target
transcription factors, the pioneer transcription factor Foxa1 had
higher prediction probabilities; it was also significantly down-
regulated in cDNA expression profile microarrays of transiently
transfected miRNA-584 into AGS cells (Figure S5). These results
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miRNA-584 and miRNA-1290.
To determine whether Foxa1 is a target molecule of miRNA-584
and miRNA-1290, we cloned a DNA fragment from the Foxa1
39UTR into the pMIR reporter vector and then co-transfected this
plasmid with miRNA-584 or miRNA-1290 into AGS cells. A
luciferase activity assay showed that co-transfection of miRNA-584
or miRNA-1290 with pMIR-Foxa1 inhibited firefly luciferase
activity by more than 90% compared with pMIR-Foxa1 alone
(Figure 4c), indicating that miRNA-584 and miRNA-1290 act on
Foxa1 mRNA. Western blot analysis showed that after transfection
with either miRNA-584 or miRNA-1290, the expression of Foxa1
protein was down-regulated approximately 50% (Figure 4d and
Figure S6). These results further indicate that Foxa1 is a target of
miRNA-584 and miRNA-1290.
Silencing Foxa1 may interfere with the normal differentiation of
gastric epithelial stem cells [27–31]. To determine the effects of
down-regulating Foxa1 on cellular function, we monitored the stem
cell ratio and EMT in cells undergoing Foxa1 silencing. Because
currently available gastric cancer cell lines mostly have low levels
of Foxa1 and E-cadherin or even do not express them, and because
H.pylori is associated with the genesis of colon cancer [32], we
selected SW620 colon cancer cells with high levels of Foxa1 and E-
cadherin expression for this study. We infected common SW620
cells with Foxa1 shRNA recombinant lentiviruses, and flow
cytometry revealed that the percentage of CD44
+CD133
+ cells
significantly decreased in Foxa1-silenced SW620 cells, P,0.05
(ANOVA). Further studies on an important stem cell–associated
molecule using western blot analysis showed that Bmi1 expression
significantly decreased during Foxa1 silencing (Figure 4e),
suggesting that silencing of Foxa1 promoted the transformation
of stem cells into progenitor cells through down-regulation of the
Bmi1 pathway. Moreover, western blot analysis showed that E-
cadherin expression decreased and vimentin expression increased
Figure 1. Screening and identification of miRNA-584 and miRNA-1290 in CagA-transfected cells. A. Detection of cagA DNA
fragments in transfected cells. The standard calcium phosphate precipitation method was used to establish stable CagA-expressing gastric
carcinoma AGS cells. Transfection was validated using PCR and DNA sequencing after cell clones had grown. AGS cells stably expressing the empty
pEGFP-c1 vector were also established as a control. B. Detection of CagA protein in transfected cells. Stable CagA-expressing gastric carcinoma
AGS cells were lysed with RIPA buffer. The lysates were subjected to SDS-PAGE and subsequently to western blot analysis to probe with anti-GFP
antibodies. AGS cells stably expressing the empty pEGFP-c1 vector were also established as a control. C. Screening and identification of miRNA-
84 and miRNA-290 in stable CagA-expressing AGS cells. Total RNA was extracted from stable CagA-expressing AGS cells and control cells.
Mammalian miRNA expression profile microarray scanning and TaqMan real-time PCR were performed. The results showed that both miRNA-584 and
miRNA-1290 were up-regulated in stable CagA-expressing AGS cells. D. Identification of miRNA-584 and miRNA-1290 in gastric carcinoma
SGC7901 cells transiently expressing CagA. Total RNA from gastric carcinoma SGC7901 cells transfected with cagA/pEGFP-c1 plasmid was
extracted and real-time PCR was performed. Both miRNA-584 and miRNA-1290 were up-regulated in transiently CagA-expressing SGC7901 cells. E.
Identification of miRNA-584 and miRNA-1290 in gastric carcinoma AGS cells infected with H.pylori. Total RNA was extracted from AGS
cells infected with H.pylori including NCTC11637 and 9 cagA– isolates for 7 h (MOI<50) respectively, and TaqMan real-time PCR was performed. Both
miRNA-584 and miRNA-1290 were up-regulated after infection of cagA+ H.pylori (all P ,0.01, ANOVA). Data are represented as mean +/2 s.e.m.
doi:10.1371/journal.pone.0035147.g001
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miRNA-1290 also decreased E-cadherin level (Figure 4g). These
results suggest that Foxa1 is a key transcription factor and that
down-regulating Foxa1 expression promotes EMT and interferes
with the differentiation of stem cells.
5. Overexpression of miRNA-584 and miRNA-1290
Induced Intestinal Metaplasia in Knock-in Mice
To explore the developmental affections of gastric epithelial
stem cell with abnormal EMT and differentiation induced by
miRNA-584 and miRNA-1290, we produced knock-in mice with
overexpression of mature miRNA-584 and miRNA-1290. The
results showed that the levels of miRNA-584 and miRNA-1290
were up-regulated about 4.32- and 2.85-fold, respectively, in
knock-in mouse, as validated by Taqman miRNA assays
(Figure 5a). Obvious morphological alterations were not
observed at the 12th week in knock-in mice. However, gastric
mucosa layers were significantly thinned and flattened, and rugal
folds had disappeared at the 72nd week (Figure 5b). Gastric
mucosa was completely replaced by large intestinal epithelium
under microscopy (Figure 5c). Muc2, an important marker of
intestinal epithelials, was significantly increased while Muc6, an
important marker of gastric epithelials, was significantly decreased
in transgenic mice (Figure 5d). Periodic Acid-Schiff (PAS)
staining showed that PAS-positive cells were also increased in in
transgenic mice (Figure 5e). These results demonstrated that
overexpression of miRNA-584 and miRNA-1290 induced trans-
differentiation of gastric epithelial cells in knock-in mice.
Discussion
Our results show that H.pylori CagA protein can up-regulate the
expression of both miRNA-584 in an NF-kB–dependent manner
and miRNA-1290 in an Erk1/2-dependent manner. miRNA-584
sustained Erk1/2 activities through inhibition of PPP2a activities,
and miRNA-1290 activated NF-kB through knockdown of NKRF.
Further luciferase reporter assays and western blot revealed Foxa1
Figure 2. miRNA-1290 was up-regulated in an Erk1/2-dependent manner and miRNA-584 was activated indirectly by miRNA-1290.
A. Determination of transactivities of Elk-1. AGS cells were transiently transfected with pGL3-Elk-1 plasmid for 24 h and subsequently infected
with H.pylori including NCTC11637 and 7 cagA+ isolates for additional 7 h (MOI<50) respectively. Cells were lysed and the lysates were collected for
determination of luminescent intensities by dual-luciferase y ¨reporter assay. The results showed that transactivities of Elk-1 was up-regulated after
infection of cagA+ H.pylori (P ,0.01, ANOVA). B. Determination of luciferase activations containing promoter region of miRNA-584 and
miRNA-1290. Plasmids containing Elk-1 or cagA were co-transfected with recombinant luciferase reporters containing promoter regions of miRNA-
584 and miRNA-1290 (<2000 bp) respectively into 293T cells for 24 h (Elk-1/cagA: luciferase reporters: Renilla luciferase=3:1:0.01). Cells were lysed
and the lysates were collected for determination of luminescent intensities by dual-luciferase_reporter assay. The results showed that miRNA-1290
was up-regulated by both Elk-1 and CagA (P ,0.01, ANOVA), whereas miRNA-584 was not affected. C. Determination of miRNA-584 in stable
miRNA-1290–expressing cells. To determine miRNA-584 in stable miRNA-1290–expressing cells, total RNA from stable miRNA-1290–expressing
cells were isolated and real-time PCR was performed for miRNA-584. The results showed that miRNA-584 was up-regulated in stable miRNA-1290–
expressing cells. D. Expression of miRNA-1290 enhanced NF-kB activities. miRNA-1290 was co-transfected with NF-kB reporter into SGC7901
cells for 24 h (miRNA-1290: luciferase reporters: Renilla luciferase=3:1:0.01). Cells were lysed and the lysates were collected for determination of
luminescent intensities by dual- luciferase_reporter assay. The results showed that miRNA-1290 enhanced NF-kB activities (P ,0.01, ANOVA). E.
Detection of NKRF protein in transfected cells. miRNA-1290-expressing gastric carcinoma SGC7901 cells were lysed and subsequently were
subjected to western blot analysis to probe with anti-NKRF antibodies. SGC7901 cells expressing the empty vector were also established as a control.
F. Knockdown of NKRF increased NF-kB activities. NKRF shRNA plasmid (Santa Cruz) was co-transfected with NF-kB reporters into SGC7901
cells for 48 h (NKRF shRNA plasmid: NF-kB reporters: Renilla luciferase=3:1: 0.1). Cells were lysed and the lysates were collected for determination of
luminescent intensities. The results showed that knockdown of NKRF increased NF-kB activities (P ,0.01, ANOVA). G. Activation of NF-kB
upregulated miRNA-584. NKRF shRNA plasmid was co-transfected with recombinant luciferase reporters containing promoter regions of miRNA-
584 into SGC7901 cells for 48 h (NKRF shRNA plasmid: luciferase reporters: Renilla luciferase=3:1: 0.1). Cells were lysed and the lysates were collected
for determination of luminescent intensities. The results showed that NF-kB up-regulated miRNA-584 (P ,0.01, ANOVA). H. Overexpression of c-
Rel upregulated miRNA-584. c-Rel plasmid was co-transfected with recombinant luciferase reporters containing promoter regions of miRNA-584
into SGC7901 cells for 48 h (c-Rel plasmid: luciferase reporters: Renilla luciferase=3:1: 0.1). Cells were lysed and the lysates were collected for
determination of luminescent intensities. The results showed that Overexpression of c-Rel upregulated miRNA-584 (P ,0.01, ANOVA). Data are
represented as mean +/2 s.e.m.
doi:10.1371/journal.pone.0035147.g002
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Knockdown of Foxa1 promoted the EMT significantly. Over-
expression of miRNA-584 and miRNA-1290 induced intestinal
metaplasia of gastric epithelial cells in knock-in mice. Thus, Erk1/
2 activitied by CagA drived miRNA-1290 expression and
subsequently miRNA-584 acivation. We speculated that different
H.pylori strains owned different ability to up-regulate miRNA-
1290, due to cagA diversity at C-terminus, in particular which from
Western strains with variable number of EPIYA repeat.
The biological functions of miRNA-584 and miRNA-1290 are
not clear. miRNA-584 is down-regulated in human renal clear cell
carcinoma and was proposed to have tumor suppressor properties
[33]. In this study, we found that miRNA-584 could inhibit Smad2
expression as shown by western blot analysis (Figure S7).
Moreover, it could inhibit PPP2a activities, which play an
important role in attenuation of the Erk1/2 pathway by direct
de-phosphorylation of Erk1/2 kinase. The inhibition of Y-Box
protein 1 in drug-sensitive gastric cancer cells can lead to increased
miRNA-1290 expression [34], whereas no other important targets
were identified. We found a strong relationship between miRNA-
1290 and miRNA-584 in clinic colon cancer tissue. miRNA-1290
could repress NKRF to enhance NF-kB activities, which may be
involved in the development and progression of cancer. Therefore,
both miRNAs were also proposed to have oncogenic properties.
One miRNA usually has hundreds of possible target genes,
making it difficult to identify the key target molecules of any
miRNA. One important intersection between miRNA interference
and signaling pathways is altered transcription factor levels;
therefore, we looked for transcription factors targeted by both
miRNA-584 and miRNA-1290. Candidate target transcription
factors were identified by using TargetScan to find transcription
factors targeted by both of these miRNAs in gastric carcinoma
AGS cells. Out of more than 1,000 transcription factors we found
15 possibly targeted by miRNA-584 and 28 possibly targeted by
Figure 3. cagA+ H.pylori activated Erk1/2 kinases and miRNA-584 sustained Erk1/2 activities through inhibition of PPP2a. A. Erk1/2
kinases were activated by CagA. AGS cells were infected with H.pylori including NCTC11637 and 9 cagA– and 7 cagA+ isolates for 7 h (MOI<50)
respectively. Cells were collected and lysed at 24 h after transfection. The lysates were co-precipitated with agarose-conjugated anti-Erk1/2
antibodies, and after washing 5 times, the beads were mixed with recombinant Elk-1 and ATP. Mixtures were subjected to SDS-PAGE after denaturing
and subsequently western blot analysis probed with antibodies against phosph-Elk-1. Uninfected AGS cells were also established as a control. B.
Determination of miRNA-584 and miRNA-1290 in transiently transfected cells. Total RNA was extracted from gastric carcinoma AGS cells
transiently transfected with plasmids containing miRNA-584 or miRNA-1290 at 24 h after transfection. Real-time PCR was performed for
determination of miRNA-584 and miRNA-1290. C. Detection of Erk1/2 activities. Gastric carcinoma AGS cells were transiently transfected with
plasmids containing miRNA-584 or miRNA-1290. Cells were collected and the lysates were co-precipitated with agarose-conjugated anti-Erk1/2
antibodies, and after washing 5 times, the beads were mixed with recombinant Elk-1 and ATP at 30uC for 30 min. Mixtures were subjected to SDS-
PAGE after denaturing and subsequently western blot analysis probed with antibodies against phosph-Elk-1. The empty vector was also established
as a control. D. Detection of PPP2ca expression. Gastric carcinoma SGC7901 cells were transiently transfected with plasmids containing miRNA-
584 or miRNA-1290. Cells were collected and lysed at 24 h after transfection. Lysates were subjected to SDS-PAGE after denaturing and subsequently
western blot analysis probed with antibodies against PPP2ca. Data are represented as mean +/2 s.e.m.
doi:10.1371/journal.pone.0035147.g003
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common to both miRNAs. Among these five possible target
transcription factors, Foxa1 had higher context scores in both the
miRNA-584 and miRNA-1290 predictions. Subsequent firefly
luciferase reporter assays and western blot analysis confirmed that
Foxa1 was knocked down by miRNA-584 and miRNA-1290. FoxA
family members include Foxa1, Foxa2, and Foxa3. Foxa1 is
expressed in the middle and late embryonic stages; Foxa1
expression significantly increases in embryonic cells after retinoic
acid induction [35]. Foxa1 and Smad2 form a complex on the a-
fetoprotein (AFP) promoter to promote AFP transcription [36].
Foxa1 is a pioneer transcription factor that can promote tissue-
specific transcription and is closely linked with epigenetic signatures
of tissues and cells [37]. Foxa1 is involved in the tissue development
of the liver, gall bladder, lung, pancreas, intestine, and prostate.
Silencing of Foxa1 and/or Foxa2 may result in abnormal de-
velopment and differentiation of those tissues and cells. Silencing of
Foxa1 increases the expression of sonic hedgehog, Foxa2, and
Notch, terminates the differentiation of prostate epithelial cells, and
causes abnormal phenotypes in glands; silencing of Foxa1 and/or
Figure 4. Foxa1 is a target of miRNA-584 and miRNA-1290 and knockdown of Foxa1 promotes EMT. A. Schematic of potential target
screening strategy. B. Transcription factor targets of miRNA-584 and miRNA-1290. Transcription factors targeted by miRNA-584 and
miRNA-1290 expressed in AGS cells were predicted by TargetScan (www. targetscan.org). C. Determination of pMIR-report luciferase activity.
The recombinant plasmid pMIR-Foxa1 report was co-transfected with pcDNA6.2-GW/EmGFP-miR containing miRNA-584 or miRNA-1290 into AGS
gastric cancer cells for 48 h. Cells were lysed and luciferase activity was determined by dual-luminescence reporter assay. Co-transfection of miRNA-
584 or miRNA-1290 with pMIR-Foxa1 inhibited more than 90% of firefly luciferase activity (all P ,0.001, ANOVA), indicating that miRNA-584 and
miRNA-1290 target Foxa1 mRNA. D. Detection of Foxa1 in cells transiently expressing miRNA-584 and miRNA-1290. pcDNA6.2-GW/
EmGFP-miR containing miRNA-584 or miRNA -1290 was transfected into SW620 colon cancer cells for 48 h. Cells (1610
6) were lysed and the
supernatant was subjected to western blot analysis. The results showed that the expression of Foxa1 protein was down-regulated about 50% after
transfection of miRNA-584 or miRNA-1290. These results indicate that Foxa1 is a target of miRNA-584 and miRNA-1290. E. Analysis of the
percentage of CD44
+CD133
+ cells. SW620 colon cancer cells were infected with recombinant Foxa1 shRNA lentivirus. Infected SW620 cells were
digested and resuspended at 1610
6 per 100 mL of PBS containing 2% FBS, and labeling antibodies (APC-CD44 and PE-CD133) were added at 4uC for
30 min in the dark. After two washes, cells were analyzed using a FACSAria. An empty vector control was also established. The percentage of
CD44
+CD133
+ cells significantly decreased after Foxa1 knockdown (P ,0.05, ANOVA). The supernatant from SW620 colon cancer cells with Foxa1
knockdown was subjected to western blot for detection of Bmi1. F. Foxa1 knockdown promotes EMT. The supernatant from SW620 colon cancer
cells with Foxa1 knockdown was subjected to SDS-PAGE, and proteins were transferred onto a nitrocellulose membrane for western blotting for
Foxa1, E-cadherin, and vimentin. G. Detection of E-cadherin in cells with stable expression of miRNA-584 or/and miRNA-1290. pcDNA6.2-
GW/EmGFP-miR containing miRNA-584 or/and miRNA -1290 was transfected into SW620 colon cancer cells. Cells were separated at 24 h after
transfection and screened by 5 mg/mL puromycin for 7 days. Survival clones were picked up and amplified respectively for 4 weeks. Cells were lysed
and the supernatant was detected for E-cadherin. GAPDH was as controls.
doi:10.1371/journal.pone.0035147.g004
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the intestine, Foxa1 and Foxa2 are only expressed in epithelial stem
cells; silencing of Foxa1 and/or Foxa2 causes goblet cell hyperplasia,
alters the properties of the secretory mucins, and causes abnormal
differentiation of enteroendocrine cells [27–31]. The functions of
Foxa1 and Foxa2 are complementary; however, we found that
Foxa1-positive cells were not perfectly coincident with Foxa2-
positive cells in gastric mucosa by immunohistochemical staining.
Foxa1-positive cells could be found in superfacial mucosa (Figure
S8), whereas Foxa2-positive cells only appeared in the bottom of
the gland.
EMT is the process of transformation from an epithelial cell
phenotype to a mesenchymal phenotype [38–40]. EMT is an
important component of the processes of cell differentiation.
During the process of cell differentiation, EMT is precisely
regulated in space and time. Our results indicate that although
miRNA-584 up-regulates Erk1/2 activity, it can induce EMT
through the inhibition of Foxa1, suggesting that the infiltrating
phenotype associated with CagA may be associated with up-
regulation of miRNA-584 and miRNA-1290. In addition, the
percentage of stem cells in Foxa1-silenced SW620 cells is
significantly lower and Bmi1 is also down-regulated. These
findings suggest that silencing of Foxa1 may promote the
transformation of stem cells into progenitor cells. Unlike RNA
interference, which has only one target, miRNA-584 and miRNA-
1290 have hundreds of possible target genes besides the mentioned
Figure 5. Overexpression of miRNA-584 and miRNA-1290 induced intestinal metaplasia in knock-in mice. A. Determination of
miRNA-584 and miRNA-1290 in knock-in mice. Total RNA was extracted from minced tissues of mice by Trizol reagent. Real-time PCR was
performed for determination of miRNA-584 and miRNA-1290. The results showed miRNA-584 and miRNA-1290 increased in knock-in mice. Data are
represented as mean +/2 s.e.m. B. Morphological observation of knock-in mice. Obvious morphological alterations were not observed at the
12th week in knock-in mice. However, gastric mucosa layers were significantly thinned and flattened, and rugal folds had disappeared at the 72nd
week C. H&E staining of gastric mucosa. Obvious morphological alterations were not observed at the 12th week in knock-in mice. However,
gastric epitheliums were replaced by intestinal metaplasia under light microscopy (6100). D. Determination of Muc 2 and Muc 6. Total RNA was
extracted from minced gastric tissues of mice by Trizol reagent. Real-time PCR was performed for determination of Muc2 and Muc6. The results
showed Muc2 was significantly increased while Muc6 was significantly decreased in transgenic mice (all P ,0.01, ANOVA). Data are represented as
mean +/2s.e.m. E. PAS staining. Gastric mucosa from transgenic mice at 72nd W were checked by PAS staining (6100). The results showed that
PAS-positive cells were increased in in transgenic mice.
doi:10.1371/journal.pone.0035147.g005
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epithelial cells with overexpression of miRNA-584 and miRNA-
1290, we observed the transition of gastric epithelial to large
intestinal epithelial by producing knock-in mice, although
miRNA-584 was not a conserved miRNA in mice.
Our study indicates that H.pylori CagA protein promotes EMT
and interferes with cell differentiation by up-regulating miRNA-
584 and miRNA-1290. Thus, the miRNA pathway is a new
pathogenic mechanism of CagA. This study provides evidence that
interference with miRNA pathways is one of the pathogenic
mechanisms of microorganisms.
Materials and Methods
Ethics Statement
This research was approved by the Institutional Review Boards
of Second Affiliated Hospital of Zhejiang University School of
Medicine. All Animal works had been conducted according to
relevant national and international guidelines.
H.pylori and cagA/pEGFP-c1 Plasmid
cagA+ H.pylori and cagA- H.pylori strains were isolated from clinic
gastric mucosa and the status of cag pathogenicity island was
identified by PCR respectively. The cagA/pEGFP-c1 plasmid was
constructed as follows: full-length cagA DNA was amplified by
PCRs from the NCTC 11637 H.pylori strain (ATCC) and
subsequently cloned into the pEGFP-c1 vector (BD Biosciences),
and the sequence of amino acid was identical to that of the NCTC
11637 strain by DNA sequencing (protein accession number:
C6K4R4).
DNA Sequences
All DNA sequences used in this study were deposited in
GenBank. FoxA1 accession number: U39840; PPP2ca accession
number: X12646; NKRF accession number: AJ011812, Smad2
accession number: U59911; cagA accession number: ACS34714.1.
Methods
1. Cell culture. Gastric carcinoma AGS, SGC7901 and
293T cells were from the Cell Bank of Chinese Academy of
Sciences (Shanghai, China). Cells were grown in RPMI 1640
culture medium (Gibco) supplemented with 100 U/ml penicillin,
100 mg/ml streptomycin, and 15% fetal bovine serum (FBS)
(Sijiqing Biotech, China); cells were passaged every 2 to 3 days.
SW620 colon cancer cells were cultured in Leibovitz’s 15 (L-15)
culture medium (Gibco) supplemented with 100 U/ml penicillin,
100 mg/ml streptomycin, and 15% FBS; 293T cells were cultured
in DMEM culture medium (Gibco) supplemented with 100 U/ml
penicillin, 100 mg/ml streptomycin, and 15% FBS;cells were
passaged every 3 to 4 days.
2. Cell transfection. The standard calcium phosphate
precipitation method (Clontech) was used to establish the stable
CagA-expressing AGS cell line. Briefly, the culture medium of
AGS cells cultured in a 35-mm culture dish was replaced with
fresh culture medium 3 h before transfection. Three micrograms
of cagA/pEGFP-c1 plasmid and 12.4 mL of 2 M CaCl2 were added
to H2O to make a 100-mL solution, which was mixed thoroughly.
The mixture was then added slowly into 100 mLo f2 6HBS
solution and placed at room temperature for 20 min. After
thorough mixing, the mixture was added onto the surface of the
cells. After culturing at 37uC for 12 h in a 5% CO2 incubator, the
medium was refreshed with new culture medium. Cells were
passaged 48 h after transfection at a 1:8 ratio; 500 mg/mL G418
(Clontech) was added the next day to select transfected cells for 7
to 10 days. Transfection was validated using PCR and DNA
sequencing after cell clones had grown. A control AGS cell line
stably expressing the empty pEGFP-c1 vector was also established.
Transient transfection of cells was performed using Lipofecta-
mine 2000 liposomes (Invitrogen) or Fugene HD (Roche) strictly
according to the manufacturer’s instructions. Eight microliters of
Lipofectamine 2000 liposomes or Fugene HD were added into
100 mL OPTI-MEM culture medium (Gibco) containing 2 mg
plasmids. This was mixed thoroughly and placed at room
temperature for 15 min. The solution was then added onto cells
cultured in 35-mm culture plates and mixed thoroughly. After
culturing at 37uC for 48 h in a 5% CO2 incubator, cells were
harvested.
3. MicroRNA screening. RNA was extracted from AGS
cells stably expressing CagA or the empty vector using Trizol
reagent (Invitrogen) and was sent to CapitalBio, Beijing, for
mammalian miRNA expression profile microarray detection,
which included 1024 miRNAs from mouse, rat, and human.
The results were compared with those from the control group;
changes that were .2-fold or ,2-fold were considered significant.
4. Real-time PCR. Detection of mature miRNAs was
performed using the TaqMan real-time PCR method (Applied
Biosystems) according to the manufacturer’s instructions. RNA
was isolated from AGS cells using Trizol; after quantitation,
reverse transcription was performed using 10 ng RNA and
primers specific for mature miR-584 or miR-1290. The reverse
transcription was run at 16uC for 30 min followed by 42uC for
30 min; the reaction was inactivated at 85uC for 5 min. The
reverse transcription products were mixed with TaqMan universal
PCR master mix II, and real-time PCR was performed. The PCR
program was 95uC for 10 min, followed by 40 cycles of 15 s at
95uC and 60 s at 60uC.
For detection of Muc2 and Muc6, RNA was isolated from gastric
tissue of transgenic mice using Trizol; after quantitation, reverse
transcription was performed using 10 ng RNA and 50 mM
oligodT15 primers. The reverse transcription was run at 37uC
for 15 min followed by 85uC for 5 s; the reaction was inactivated
at 85uC for 5 min. The reverse transcription products were mixed
with specific primers and probes for Muc2 and Muc6, and real-time
PCR (Takara) was performed. Muc2 top: 59-aatggcatgc agaccaatta-
39. bottom: 59-tcttctgcatgttcccaaac-39. Probe: 5’Fam-caatggcact-
gaactgtatgccttcc -3’Tamra. Muc6: top: 59-tctccactgttgctgtctcc-39.
bottom: 59-acgaggtctga ggagctgat-39. Probe: 5’Fam-tgca gaccacc
attgcctccc-39Tamra. The PCR program was 95uC for 30s min,
followed by 40 cycles of 5 s at 95uC and 34s at 60uC.
5. Construction of miR-584 and miR-1290 expression
plasmids. ThesequencesofmaturemiR-584andmiR-1290were
chemically synthesized as follows. miRNA -584 top: 59-
ctagtagtttacaggtctgtggcaatactcttaaccataag aattgaaatggta-39;
bottom: 59-agcttaccatttcaattcttatggttaagagtattgcc
acagacctgtaaacta-39. miRNA-1290 top: 59-
ctagtaacgtggtccaagattcaaaaa tcctattgatagtggccattta-39; bottom: 59-
agcttaaatggccactatcaataggattt ttgaatcttggaccacgtta-39. After
denaturation at 95uC for 4 min, 4 mL of 10 nM oligos were
ligated with 2 mL of 5 ng/mL linearized pcDNA6.2-GW/
EmGFP-miR plasmid (Invitrogen) using T4 DNA ligase at
room temperature for 1 h. The ligation mixture was
transformed into TOP10 cells (Invitrogen), and colonies were
selected by 50 mg/mL spectinomycin. Colonies were amplified
to extract plasmids for DNA sequence identification.
6. Detection of pMIR-Foxa1 report luciferase
activity. DNA fragments from the Foxa13 9UTR that might
interact with miR-584 and miRNA-1290 were chemically
synthesized. miRNA-584 top: 59-ctagtatagcaat
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ggcgtattaatgctatggttatcaatctccaagaatattgctata-39.miRNA-1290top:
59-ctagtcaaaccgtcaacagcataataaaatcccaacaactatttttatttcattttt ca-39;
bottom: 59-agcttgaaaaatgaaataaaaatagttgttgggattttattatgctgtt
gacggtttga-39. DNA fragments were re-natured at 90uC for 3 min
followedby37uCfor60 min.ThedsOligoswerethenligatedintothe
SpeI/HindIIIsitesintheMCSoflinearizedpMIR-reportluciferase
plasmid (3:1)(Ambion)usingT4ligaseatroomtemperaturefor 1 h.
The ligation mixture was then transformed into E. coli DH5a.
Colonieswereselectedby100 mg/mLampicillin.Colonieswerethen
amplified to extract plasmid for DNA sequence identification. To
assess pMIR luciferase activity, recombinant pMIR-Foxa1 plasmids
were co-transfected with pcDNA6.2-GW/EmGFP-miR plasmids
containing miRNA-584 or miRNA-1290 into gastric carcinoma
AGS cells for 48 h. Cells were harvested, and luciferase activity was
determined by dual-luminescence reporter assay (Promega).
7. Construction of promoter of miR-584 and miR-1290
luciferase reporter plasmids. The promoter sequences of
miR-584 and miR-1290 were amplified by the following primers:
miRNA-584 top: 59-agtctgtggtaccggtggggaagtc agagatga-39;
bottom: 59-agtctgtaagctttccctgaagcaaccttcttg-39. miRNA-1290 top:
59-agtctgtg gtacccccaacctttctcagagcag-39; bottom: 59-
agtctgtaagctttggcattgggt ctttctttc-39. After PCR, the products were
digested by Kpn I and Hind III and ligated with linearized pGL3
plasmid (Promega) using T4 DNA ligase at 22uC overnight. The
ligationmixturewastransformedintoE.coliDH5acells,andcolonies
were selected by 100 mg/mL ampicillin. Colonies were amplified to
extract plasmids for DNAsequence identification.
8. Western blotting. Cells (1610
6) were harvested and
washed with phosphate-buffered saline (PBS) twice. They were
then lysed with 350 mL radio-immunoprecipitation assay (RIPA)
buffer containing 1% NP-40, 0.25% sodium deoxycholate, 5 mM
DL-Dithiothreitol (DTT), and 16 protease inhibitor cocktail on
ice for 5 min. The cell lysate was centrifuged at 13,000 g for
10 min, and the supernatant was mixed with an equal volume of
sample buffer. After 10% sodium dodecyl sulfate–polyacrylamide
gel electrophoresis (SDS-PAGE), proteins were transferred onto
a nitrocellulose membrane. After blocking with 5% non-fat milk at
room temperature for 30 min, the membrane was washed three
times and then incubated with diluted primary antibodies: Foxa1
antibody (Abcam) and antibodies to Bmi1, E-cadherin, vimentin,
PPP2ca and NKRF (Epitopmics) at room temperature for 2 h or
4uC overnight. After five washes, the membrane was incubated
with a 1:2,000 dilution of horseradish peroxidase (HRP)-labeled
goat anti-rabbit antibody at room temperature for 1 h. The
membrane was developed using enhanced chemiluminescence
(ECL) (Cellsignal Biotech) after five washes.
9. Recombinant lentivirus infection. Five thousand
SW620 colon cancer cells were cultured in a 12-well plate at
37uC overnight in a 5% CO2 incubator. The culture medium was
changed to fresh medium containing 8 mg/mL polybrene (Sigma)
the next day, and 25 mL of recombinant lentivirus solution (Santa
Crutz) were added for 24 h at 37uC in a 5% CO2 incubator. The
culture medium was then changed, and the cells were digested and
passaged at a 1:8 ratio when the cells were 2/3 confluent.
Puromycin (5 mg/mL) (Clontech) was added the next day to select
for lentivirus-infected cells for 7 to 10 days. After colonies had
grown, western blot analysis was performed for identification. An
empty vector was transfected as a control.
10. Flow cytometry. SW620 colon cancer cells infected with
recombinant lentivirus were digested with 0.25% trypsin, and cells
were then collected by centrifugation at 1,500 g for 5 min. The
cells were washed twice with PBS containing 2% FBS and blocked
in buffer on ice for 10 min. After centrifugation at 2,000 g for
3 min, the cells were resuspended at 1610
6 per 100 mL of buffer.
Labeling antibodies (15 mL APC-CD44 and 15 mL PE-CD133)
(Miltenyi) were added at 4uC for 30 min in the dark. After
centrifugation, the cells were washed with buffer twice and
resuspended in 500 mL buffer. They were then analyzed using
a FACSAria cell sorter (BD Biosciences). A blank control and an
isotype control were included.
11. Production of miRNA-584 and miRNA-1290 knock-in
mice. The production of mice with overexpression of mature
miRNA-584 and miRNA-1290 was performed by Shanghai
Innovation Biotechnology Co. Ltd. Briefly, mature sequences of
miRNA-584 and miRNA-1290 from pcDNA6.2-GW/EmGFP-
miR plasmids were cloned into BLOCK-iT
TM Lentiviral Pol II
miR RNAi expression vectors (Invitrogen) and transfected into
FT293 cells (Invitrogen) to produce recombinant lentivirus.
Subsequently densed lentivirus particles were injected into
oosphere cells of C57BL6 mice for the production of mice with
overexpression of mature miRNA-584 and miRNA-1290. Finally,
the levels of miRNA-584 and miRNA-1290 were validated by
Taqman miRNA assays.
12. Infection model. 1610
5/well AGS cells were seeded into
a 12-well plate at 37uC overnight in a 5% CO2 incubator for 24 h.
Subsequently cells were infected with H.pylori including
NCTC11637 and 9 cagA– isolates for additional 7 h (MOI<50)
respectively, and TaqMan real-time PCR was performed.
Supporting Information
Figure S1 Putative Elk-1 binding sites in the promoter
regions of miRNA-584 and miRNA-1290.
(DOC)
Figure S2 Relationship between miRNA-584 and
miRNA-1290 in clinic tumor. tissues. Total RNA from 9
pairs of human primary colon cancer tissues were isolated and
real-time PCR was performed for miRNA-84 and miRNA-290.
The results showed a strong relationship between miRNA-584 and
miRNA-1290 in clinic tumor tissue samples.
(DOC)
Figure S3 Putative c-Rel binding sites in the promoter
regions of miRNA-584.
(DOC)
Figure S4 Putative binding sites of miRNA-584 in 39-
UTR of PPP2a.
(DOC)
Figure S5 Foxa1 expression is lower in AGS cells
transiently expressing miRNA-584. The plasmid
pcDNA6.2-GW/EmGFP-miR containing mature miRNA-584
was transiently transfected into AGS cells with Lipofectamine
2000. Total RNA was extracted, and human cDNA genechip
scanning was performed. Differential genes were identified by real-
time PCR. The results show that Foxa1 expression is lower in AGS
cells transiently expressing miRNA-584.
(DOC)
Figure S6 Normalized protein expression of Foxa1.
Densitometric analysis of bands corresponding to Foxa1 and
GAPDH was performed using Quantity-One software (Bio-Rad).
The expression of Foxa1 protein was down-regulated about 50%
after transfection of miRNA-584 or miRNA-1290 (P ,0.01 and P
,0.05, ANOVA. Data are represented as mean +/– s.e.m.).
Protein expression was normalized to GAPDH.
(DOC)
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Smad2. pcDNA6.2-GW/EmGFP -miR containing the mature
miRNA-584 DNA sequence was transiently transfected into AGS
cells with Lipofectamine 2000 for 48 h. Cells were harvested and
lysed. The supernatant of the lysate was subject to SDS-PAGE,
and proteins were transferred onto a nitrocellulose membrane.
After blocking with non-fat milk, the membrane was incubated
with anti-Smad2 antibody and diluted HRP-labeled goat anti-
rabbit antibody. Finally. the membrane was developed using ECL
substrate.
(DOC)
Figure S8 Expression of FoxA1 in gastric epithelial cells.
Gastric mucosa from a patient with H.pylori infection was sliced
after fixation with formalin. The slices were analyzed by
immunohistochemical staining after antigen retrieval.
(DOC)
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